METHODE DE TRAITEMENT DU CANCER DE L'OVAIRE ET DU REIN UTILISANT DES ANTICORPS DIRIGES CONTRE L'ANTIGENE A DOMAINE 1 DE MUCINE ET A DOMAINE IMMUNOGLOBULINE DES LYMPHOCYTES T (TIM-1)
The invention described herein is related to antibodies directed to the antigen TIM-1 and uses of such antibodies for the treatment of cancer (e.g., renal and ovarian cancer). In particular, there are provided fully human monoclonal antibodies directed to the antigen TIM-1. Isolated polynucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions (FR's) and/or complementarity determining regions (CDR's), specifically from FR1 though FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.
